본문으로 건너뛰기
CAS 기록 0건

CAS 106685-40-9

CAS 106685-40-9은(는) 규정 1223/2009의 부속서 II–VI에 걸쳐 EU 부속서 기록 0건과 일치합니다.

CAS 106685-40-9의 기록

0 총
이 CAS 번호에 대한 기록을 찾을 수 없습니다.

화학적 정체 및 특성

CAS 106685-40-9의 PubChem 2D 화학 구조
CAS 106685-40-9PubChem CID 60164

Adapalene

Adapalene is a naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether. It has a role as a non-steroidal anti-inflammatory drug, a dermatologic drug and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It is a monocarboxylic acid, a naphthoic acid and a member of adamantanes. It is functionally related to a CD437. — ChEBI

IUPAC 명칭
6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid
분자식
C28H28O3
분자량
412.5 g/mol
정확한 질량
412.20384475 Da
XLogP3
7.7
위상 극성 표면적
46.5 Ų
수소 결합 공여체
1
수소 결합 수용체
3
공유결합 단위
1
정의된 입체중심
0

다른 이름

DifferinAdaferinAdapalenoCD-271AdapalenumDifferineCD 2716-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid
보고된 명칭 16개 더 보기
CD2716-[3-(1-Adamantyl)-4-methoxyphenyl]-2-naphthoic acid6-(4-Methoxy-3-tricyclo[3.3.1.13,7]dec-1-ylphenyl)-2-naphthalenecarboxylic acid1L4806J2QF6-[3-(adamantan-1-yl)-4-methoxyphenyl]naphthalene-2-carboxylic acidIDP-126 Component AdapaleneCHEBI:31174CABTREO COMPONENT ADAPALENE2-Naphthalenecarboxylic acid, 6-(4-methoxy-3-tricyclo(3.3.1.1(sup 3,7))dec-1-ylphenyl)-AdaplaeneEffaclarAdapalene Gel6-(3-(adamantan-1-yl)-4-methoxyphenyl)naphthalene-2-carboxylic acidProactiv MD Kit6-(4-Methoxy-3-tricyclo(3.3.1.13,7)dec-1-ylphenyl)-2-naphthalenecarboxylic AcidCurist Acne Relief
외부 데이터베이스 식별자

추가 과학 데이터베이스의 근거

EMBL-EBI ChEBI
식별자 정확히 일치CHEBI:31174

adapalene

A naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether.

처방
C28H28O3
평균 질량
412.529 g/mol
단일 동위원소 질량
412.20384 Da
형식 전하
0
  • naphthoic acid — is a (CHEBI:25483)
  • monocarboxylic acid — is a (CHEBI:25384)
  • adamantanes — is a (CHEBI:51339)
  • dermatologic drug — has role (CHEBI:50177)
  • non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
  • EC 2.7.11.22 (cyclin-dependent kinase) inhibitor — has role (CHEBI:82665)
  • CD437 — has functional parent (CHEBI:88334)
  • dermatologic drug — has role (CHEBI:50177)
  • non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
  • EC 2.7.11.22 (cyclin-dependent kinase) inhibitor — has role (CHEBI:82665)
  • naphthoic acid — is a (CHEBI:25483)
  • monocarboxylic acid — is a (CHEBI:25384)
  • adamantanes — is a (CHEBI:51339)
추가 선별 명칭
6-(3-adamantan-1-yl-4-methoxyphenyl)naphthalene-2-carboxylic acid6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acidCD 271CD-271
이 출처의 상호 참조

매핑 기준: Exact CAS cross-reference in the ChEBI compound record. 출처 업데이트: 2017-02-22. 가져온 시각: 2026-08-31. 출처 기록 열기

NIH PubChem PUG-View
식별자 정확히 일치60164

Attributed physical-property, hazard, environmental and use annotations.

  • Exposure Routes: Absorption of adapalene through human skin is low. Only trace amounts (<0.25 ng/mL) of parent substance have been found in the plasma of acne patients following chronic topical application of adapalene in controlled clinical trials 출처: Toxin and Toxin Target Database (T3DB)
  • Note: This chemical does not meet GHS hazard criteria for 9.1% (1 of 11) of reports. 출처: European Chemicals Agency (ECHA)
  • Signal: Warning 출처: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (18.2%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (72.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (54.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (72.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (18.2%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H361 (81.8%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] 출처: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) 출처: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 11 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 11 reports by companies.; There are 6 notifications provided by 10 of 11 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 출처: European Chemicals Agency (ECHA)
  • Toxicity Summary: If the adapalene is applied excessively, marked redness, scaling, or skin discomfort may occur. In addition, according to product labeling, chronic ingestion of the drug may lead to the same adverse drug reactions associated with excessive oral intake of vitamin A. 출처: StatPearls
  • Toxicity Summary: Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation. 출처: Toxin and Toxin Target Database (T3DB)
  • Uses: Use (kg) in USA (2002): 78; Consumption (g per capita) in the USA (2002): 0.000278; Calculated removal (%): 97.7 출처: NORMAN Suspect List Exchange
  • Uses: For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back. 출처: Toxin and Toxin Target Database (T3DB)

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
EMBL-EBI ChEBI정확히 일치2026-08-31
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-08-31에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

이 사이트에서 CAS 106685-40-9을(를) 사용하는 방식

CAS 106685-40-9은(는) 이 페이지를 특정 물질에 고정하는 데 사용하는 Chemical Abstracts Service 식별자입니다. 현재 데이터세트에서는 EU 부속서 기록 0건이 이 식별자를 공유하며, 같은 물질이 하나의 규제 맥락에 나타나는지 여러 맥락에 나타나는지 교차 확인하는 데 도움이 됩니다.

공급업체 규격서, SDS 또는 원료 문서에 CAS 106685-40-9이(가) 제시되어 있고 연결된 모든 부속서 II–VI 기록을 한곳에서 확인해야 할 때 이 페이지를 이용하세요. 위의 항목 카드는 농도 한도, 경고 문구, 부속서 위치 및 제품 유형 조건을 가장 빠르게 확인하는 방법입니다.